Proliferating myoblasts express MyoD, yet no phenotypic markers are activat
ed as long as mitogen levels are sufficient to keep the cells dividing. Dep
ending upon mitogen levels, a decision is made in ct that commits the myobl
ast to either continue to divide or to exit from the cell cycle and activat
e terminal differentiation. Ectopic expression of MyoD under the control of
the RSV or CMV promoters causes 10T1/2 cells to rapidly exit the cell cycl
e and differentiate as single myocytes, even in growth medium, whereas expr
ession of MgoD under the weaker SV40 promoter is compatible with proliferat
ion. Coexpression of MyoD and cyclin D1, but not cyclins A, B, E or D3, blo
cks transactivation of a MyoD responsive reporter. Similarly, transfection
of myoblasts with the cyclin-dependent kinase (cdk) inhibitors p16 and p21
supports some muscle-specific gene expression even in growth medium. Taken
altogether, these results suggest cell cycle progression negatively regulat
es myocyte differentiation, possibly through a mechanism involving the D1 r
esponsive cdks. We review evidence coupling growth status, the cell cycle a
nd myogenesis. We describe a novel mitogen-sensitive mechanism that involve
s the cyclin D1-dependent direct interaction between the G1 cdks and MyoD i
n the dividing myoblast, which regulates MyoD function in a mitogen-sensiti
ve manner. (C) 2001 Federation of European Biochemical Societies. Published
by Elsevier Science B.V. All rights reserved.